Allergan Bats Its Eyes At Consumers With Latisse Marketing Campaign
Executive Summary
Allergan is charting new territory in marketing its eyelash growth stimulant Latisse, a product with a purely aesthetic indication that will be uniquely consumer-driven
You may also be interested in...
Fibrocell's Wrinkle Drug Underlines Challenges Of Seeking Aesthetic Claims
An FDA advisory committee made very clear that the bar should be much higher for novel products proposed for aesthetic indications than for drugs to treat diseases during the Oct. 9 review of Fibrocell Science's wrinkle therapy Laviv (azfibrocel-T)
Fibrocell's Wrinkle Drug Underlines Challenges Of Seeking Aesthetic Claims
An FDA advisory committee made very clear that the bar should be much higher for novel products proposed for aesthetic indications than for drugs to treat diseases during the Oct. 9 review of Fibrocell Science's wrinkle therapy Laviv (azfibrocel-T)
Allergan Adapts Trial Design; Latisse Endpoints Based On Consumer Feedback
The clinical trial endpoints for Allergan's eyelash stimulant drug, Latisse, were determined through discussions with consumer panels about what was most desired in a drug that enhances eyelashes